3D Signatures (DXD) Stock Price, News & Analysis

Company Overview

3D Signatures Inc., a personalized medicine company, focuses on the development and commercialization of predictive technological products. Its proprietary software platform predicts the course of certain diseases and personalizes the treatment for individual patients. The company's TeloView software platform measures the stage of the disease, rate of progression of the disease, how different diseases will respond to various therapies, and drug efficacy and toxicity. It is developing five diagnostic and prognostic products for cancers and neurological disorders, including Hodgkin's lymphoma, prostate cancer, multiple myeloma, lung cancer, and Alzheimer's diseases. The company is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$0.04 to C$0.04
• 50-Day Range: C$0.04 to C$0.04
• 52-Week Range: C$0.03 to C$0.25
• Volume: 5,000 shs
• Average Volume: 30,759 shs
• Market Capitalization: C$2.66 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DXD Stock Analysis - Frequently Asked Questions

How have DXD shares performed this year?

3D Signatures' stock was trading at C$0.04 at the beginning of the year. Since then, DXD stock has increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2025 here.

How do I buy shares of 3D Signatures?

Shares of DXD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of 3D Signatures own?

Based on aggregate information from My MarketBeat watchlists, some other companies that 3D Signatures investors own include First Majestic Silver (AG), QUALCOMM (QCOM), Aurora Cannabis (ACB), Alio Gold Inc. (ALO.TO) (ALO), Boxlight (BOXL), Frontier Lithium (FL) and Leaf Mobile (LEAF).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: CVE:DXD
• CIK: N/A
• Web: www.3dsignatures.com
• Phone: +1-204-5820922
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.08
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 22.50
• Book Value: C($0.01) per share
• Price / Book: -3.64

Miscellaneous

• Outstanding Shares: 66,532,000
• Free Float: N/A
• Market Cap: C$2.66 million
• Optionable: Not Optionable
• Beta: N/A